Russell Alan J

SEC Form 4 insider
Chief Scientific Officer · Edgewise Therapeutics, Inc. ($EWTX)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d000———
3d111100%-0.3%-0.3%
1w1100%+0.0%+0.0%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$EWTXSEC Form 4bearish
Sold 5,901 @ $43.73 avg · $258,042 · 2026-08-12

Form 4: Russell Alan J sold EWTX

Russell Alan J (Chief Scientific Officer at Edgewise Therapeutics, Inc.) reported an open-market sale of 5,901 shares of EWTX at an average $43.73, roughly $258,042, in a Form 4 filed 2026-08-14.

At post $44.17Now $45.32+2.6% since postedas of Sep 18, 4:30 PM ET
1d—
3d-0.3%
1w+0.0%
1m+0.5%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.